Center-Authored Papers

Filters: Author is Medeiros, Bruno C  [Clear All Filters]
Journal Article
Garcia JS, Medeiros BC, Appelbaum FR.  2012.  Blood consult: monosomal karyotype acute myeloid leukemia.. Blood.
Medeiros BC, Othus M, Appelbaum FR.  2011.  Cytarabine dose for acute myeloid leukemia.. The New England journal of medicine. 364(22):2167-8;authorreply2168-9.
Medeiros BC, Othus M, Fang M, Appelbaum FR, Erba HP.  2015.  Cytogenetic heterogeneity negatively impacts outcomes in patients with acute myeloid leukemia.. Haematologica. 100(3):331-5. Abstract
Sorror ML, Storer BE, Fathi AT, Gerds AT, Medeiros BC, Shami P, Brunner AM, Sekeres MA, Mukherjee S, Peña E et al..  2017.  Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality.. JAMA oncology. Abstract
Becker PS, Medeiros BC, Stein AS, Othus M, Appelbaum FR, Forman SJ, Scott BL, Hendrie PC, Gardner KM, Pagel JM et al..  2015.  G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.. American journal of hematology. 90(4):295-300. Abstract
Walter RB, Medeiros BC, Gardner KM, Orlowski KF, Gallegos L, Scott BL, Hendrie PC, Estey EH.  2013.  Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase 1/2 study.. Haematologica. Abstract
Medeiros BC, Othus M, Estey EH, Fang M, Appelbaum FR.  2012.  Impact of body-mass index in the outcome of adult patients with acute myeloid leukemia.. Haematologica. 97(9):1401-1404. Abstract
Medeiros BC, Othus M, Fang M, Appelbaum FR, Estey EH.  2012.  Impact of residual normal metaphases in core binding factor acute myeloid leukemia.. Cancer. 118(9):2420-2423. Abstract
Xie B, Othus M, Medeiros BC, Fang M, Appelbaum FR, Estey EH.  2011.  Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype.. Haematologica. 96(4):631-2.
Pierceall WE, Lena RJ, Medeiros BC, Blake N, Doykan C, Elashoff M, Cardone MH, Walter RB.  2014.  Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.. Leukemia research. 38(5):564-8. Abstract
Stone RM, Mandrekar SJ, Sanford BL, Laumann K, Geyer S, Bloomfield CD, Thiede C, Prior TW, Döhner K, Marcucci G et al..  2017.  Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.. The New England journal of medicine. Abstract
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C et al..  2011.  Multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(10):1146-83.
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Chanan-Khan A, Cohen AD, Devine S, Djulbegovic B, Gasparetto C, Huff CA et al..  2009.  NCCN clinical practice guidelines in oncology: multiple myeloma.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(9):908-42.
VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M et al..  2016.  NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.. Journal of the National Comprehensive Cancer Network : JNCCN. 14(11):1357-1370. Abstract
Lewinsohn M, Brown AL, Weinel LM, Phung C, Rafidi G, Lee MK, Schreiber AW, Feng J, Babic M, Chong C-E et al..  2015.  Novel germline DDX41 mutations define families with a lower age of MDS/AML onset, and lymphoid malignancies.. Blood. Abstract
Walter RB, Medeiros BC, Powell BL, Schiffer CA, Appelbaum FR, Estey EH.  2012.  Phase 2 trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia.. Haematologica. 97(5):739-742. Abstract
Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR.  2010.  Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.. Blood. 116(13):2224-8. Abstract
Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AKP et al..  2014.  Senior adult oncology, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(1):82-126. Abstract
Medeiros BC, Othus M, Estey EH, Fang M, Appelbaum FR.  2014.  Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia.. British journal of haematology. 164(2):245-50. Abstract
Anderson KC, Alsina M, Bensinger WI, Biermann SJ, Cohen AD, Devine S, Djulbegovic B, Faber EA, Gasparetto C, Hernandez-Ilizaliturri F et al..  2012.  Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2013.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(10):1211-1219. Abstract